TY - JOUR
T1 - HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons
AU - Kishinevsky, Sarah
AU - Wang, Tai
AU - Rodina, Anna
AU - Chung, Sun Young
AU - Xu, Chao
AU - Philip, John
AU - Taldone, Tony
AU - Joshi, Suhasini
AU - Alpaugh, Mary L.
AU - Bolaender, Alexander
AU - Gutbier, Simon
AU - Sandhu, Davinder
AU - Fattahi, Faranak
AU - Zimmer, Bastian
AU - Shah, Smit K.
AU - Chang, Elizabeth
AU - Inda, Carmen
AU - Koren, John
AU - Saurat, Nathalie G.
AU - Leist, Marcel
AU - Gross, Steven S.
AU - Seshan, Venkatraman E.
AU - Klein, Christine
AU - Tomishima, Mark J.
AU - Erdjument-Bromage, Hediye
AU - Neubert, Thomas A.
AU - Henrickson, Ronald C.
AU - Chiosis, Gabriela
AU - Studer, Lorenz
N1 - Funding Information:
We thank the D. Krainc lab for providing the PD iPSC lines, Elizabeth Calder, Sonja Kriks, Justine Miller, Jae-Won Shim, Julius Steinbeck, for technical advice, support and data interpretation. We further thank A. Rajadhyaksha and D. Eliezer for critical discussions on the project. The work was supported in part by the National Institute of Neurological Disorders and Stroke (NINDS) grant NS052671 and NYSTEM contract C028503 to L.S. and by R01 CA172546, U01 AG032969, R56 AG061869, P01 CA186866, P30 CA08748, P50 CA192937 and R21 AG028811 from the NIH and the Coins for Alzheimer’s Research Trust (CART) Fund to G.C. This work was further supported by grants from the Parkinson’s disease and Jeffry and Barbara Picower Foundations, a core grant P30 CA08748 from the NIH, and the BMBF project NeuriTox. S.K. was supported by an NRSA F31 (NIH) pre-doctoral fellowship from NINDS, and T.W. by a Lymphoma Research Foundation postdoctoral fellow grant. C.K. is supported by the DFG (FOR2488).
Publisher Copyright:
© 2018, The Author(s).
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Environmental and genetic risk factors contribute to Parkinson’s Disease (PD) pathogenesis and the associated midbrain dopamine (mDA) neuron loss. Here, we identify early PD pathogenic events by developing methodology that utilizes recent innovations in human pluripotent stem cells (hPSC) and chemical sensors of HSP90-incorporating chaperome networks. We show that events triggered by PD-related genetic or toxic stimuli alter the neuronal proteome, thereby altering the stress-specific chaperome networks, which produce changes detected by chemical sensors. Through this method we identify STAT3 and NF-κB signaling activation as examples of genetic stress, and phospho-tyrosine hydroxylase (TH) activation as an example of toxic stress-induced pathways in PD neurons. Importantly, pharmacological inhibition of the stress chaperome network reversed abnormal phospho-STAT3 signaling and phospho-TH-related dopamine levels and rescued PD neuron viability. The use of chemical sensors of chaperome networks on hPSC-derived lineages may present a general strategy to identify molecular events associated with neurodegenerative diseases.
AB - Environmental and genetic risk factors contribute to Parkinson’s Disease (PD) pathogenesis and the associated midbrain dopamine (mDA) neuron loss. Here, we identify early PD pathogenic events by developing methodology that utilizes recent innovations in human pluripotent stem cells (hPSC) and chemical sensors of HSP90-incorporating chaperome networks. We show that events triggered by PD-related genetic or toxic stimuli alter the neuronal proteome, thereby altering the stress-specific chaperome networks, which produce changes detected by chemical sensors. Through this method we identify STAT3 and NF-κB signaling activation as examples of genetic stress, and phospho-tyrosine hydroxylase (TH) activation as an example of toxic stress-induced pathways in PD neurons. Importantly, pharmacological inhibition of the stress chaperome network reversed abnormal phospho-STAT3 signaling and phospho-TH-related dopamine levels and rescued PD neuron viability. The use of chemical sensors of chaperome networks on hPSC-derived lineages may present a general strategy to identify molecular events associated with neurodegenerative diseases.
UR - http://www.scopus.com/inward/record.url?scp=85055076176&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055076176&partnerID=8YFLogxK
U2 - 10.1038/s41467-018-06486-6
DO - 10.1038/s41467-018-06486-6
M3 - Article
C2 - 30341316
AN - SCOPUS:85055076176
SN - 2041-1723
VL - 9
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 4345
ER -